S Tomczyk, V Zanichelli, ML Grayson… - Clinical Infectious …, 2019 - academic.oup.com
Abstract Carbapenem-resistant Enterobacteriaceae (CRE), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPsA) are a serious cause of healthcare …
YK Kang, K Kwon, JS Ryu, HN Lee, C Park… - Bioconjugate …, 2017 - ACS Publications
The overuse of antibiotics plays a major role in the emergence and spread of multidrug- resistant bacteria. A molecularly targeted, specific treatment method for bacterial pathogens …
The wide dissemination of carbapenemase-producing Gram-negatives (CPGNs), including enterobacterial species and non-fermenters, has caused a public health crisis of global …
Recent reports have revealed the existence of widespread extensively drug-resistant (XDR) P. aeruginosa high-risk clones in health care settings, but there is still scarce information on …
Y Li, JA Roberts, MM Walker, AT Aslan… - International Journal of …, 2024 - Elsevier
Objectives The objective of this systematic review and meta-analysis was to estimate the global prevalence of multi-drug resistant (MDR) Pseudomonas aeruginosa causing …
ABSTRACT A limited number of Pseudomonas aeruginosa genotypes (mainly ST-111, ST- 175, and ST-235), known as high-risk clones, are responsible for epidemics of nosocomial …
M Buhl, S Peter, M Willmann - Expert review of anti-infective …, 2015 - Taylor & Francis
Pseudomonas aeruginosa is a Gram-negative human pathogen with extensively drug- resistant (XDR) strains emerging in hospitals across the globe. This systematic review is …
Healthcare-associated infections (HAIs) caused by multidrug-resistant organisms (MDROs) represent a global threat to human health and well-being. Because transmission of MDROs …
AF Voor in 't holt, JA Severin… - Antimicrobial agents …, 2014 - Am Soc Microbiol
ABSTRACT A systematic review and meta-analyses were performed to identify the risk factors associated with carbapenem-resistant Pseudomonas aeruginosa and to identify …